Anticoagulants Industry Research Report 2024
Summary
Anticoagulants, commonly referred to as blood thinners, are substances that prevent or reduce coagulation of blood, prolonging the clotting time. Some of them occur naturally in blood-eating animals such as leeches and mosquitoes, where they help keep the bite area unclotted long enough for the animal to obtain some blood. As a class of medications, anticoagulants are used in therapy for thrombotic disorders. Oral anticoagulants (OACs) are taken by many people in pill or tablet form, and various intravenous anticoagulant dosage forms are used in hospitals. Some anticoagulants are used in medical equipment, such as test tubes, serum-separating tubes, blood transfusion bags, and dialysis equipment.
According to APO Research, The global Anticoagulants market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
North American market for Anticoagulants is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Anticoagulants is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Anticoagulants is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global companies of Anticoagulants include Sanofi, Bristol-Myers Squibb, Bayer, Johnson & Johnson., Genentech (Roche), Boehringer Ingelheim, Lilly, Daiichi Sankyo and Otsuka, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Anticoagulants, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anticoagulants.
The Anticoagulants market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Anticoagulants market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Anticoagulants market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Anticoagulants and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Anticoagulants.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Anticoagulants companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
Anticoagulants, commonly referred to as blood thinners, are substances that prevent or reduce coagulation of blood, prolonging the clotting time. Some of them occur naturally in blood-eating animals such as leeches and mosquitoes, where they help keep the bite area unclotted long enough for the animal to obtain some blood. As a class of medications, anticoagulants are used in therapy for thrombotic disorders. Oral anticoagulants (OACs) are taken by many people in pill or tablet form, and various intravenous anticoagulant dosage forms are used in hospitals. Some anticoagulants are used in medical equipment, such as test tubes, serum-separating tubes, blood transfusion bags, and dialysis equipment.
According to APO Research, The global Anticoagulants market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
North American market for Anticoagulants is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Anticoagulants is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Anticoagulants is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global companies of Anticoagulants include Sanofi, Bristol-Myers Squibb, Bayer, Johnson & Johnson., Genentech (Roche), Boehringer Ingelheim, Lilly, Daiichi Sankyo and Otsuka, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Anticoagulants, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anticoagulants.
The Anticoagulants market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Anticoagulants market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
- Sanofi
- Bristol-Myers Squibb
- Bayer
- Johnson & Johnson.
- Genentech (Roche)
- Boehringer Ingelheim
- Lilly
- Daiichi Sankyo
- Otsuka
- AstraZeneca
- Pfizer
- Aspen
- The Medicines Company
- Platelet Aggregation Inhibitors (PAI)
- Low-Molecular-Weight Heparin (LMWH)
- Direct Thrombin Inhibitor (DTI)
- Direct Factor Xa Inhibitors (DFXa)
- Vitamin K antagonists (VKA)
- Others
- VTE
- ACS/MI
- AF
- Others
- North America
- United States
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Nordic Countries
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Anticoagulants market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Anticoagulants and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Anticoagulants.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Anticoagulants companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
1 PREFACE
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 MARKET OVERVIEW
2.1 Product Definition
2.2 Anticoagulants by Type
2.2.1 Market Value Comparison by Type (2019 VS 2023 VS 2030)
2.2.2 Platelet Aggregation Inhibitors (PAI)
2.2.3 Low-Molecular-Weight Heparin (LMWH)
2.2.4 Direct Thrombin Inhibitor (DTI)
2.2.5 Direct Factor Xa Inhibitors (DFXa)
2.2.6 Vitamin K antagonists (VKA)
2.2.7 Others
2.3 Anticoagulants by Application
2.3.1 Market Value Comparison by Application (2019 VS 2023 VS 2030)
2.3.2 VTE
2.3.3 ACS/MI
2.3.4 AF
2.3.5 Others
2.4 Assumptions and Limitations
3 ANTICOAGULANTS BREAKDOWN DATA BY TYPE
3.1 Global Anticoagulants Historic Market Size by Type (2019-2024)
3.2 Global Anticoagulants Forecasted Market Size by Type (2025-2030)
4 ANTICOAGULANTS BREAKDOWN DATA BY APPLICATION
4.1 Global Anticoagulants Historic Market Size by Application (2019-2024)
4.2 Global Anticoagulants Forecasted Market Size by Application (2019-2024)
5 GLOBAL GROWTH TRENDS
5.1 Global Anticoagulants Market Perspective (2019-2030)
5.2 Global Anticoagulants Growth Trends by Region
5.2.1 Global Anticoagulants Market Size by Region: 2019 VS 2023 VS 2030
5.2.2 Anticoagulants Historic Market Size by Region (2019-2024)
5.2.3 Anticoagulants Forecasted Market Size by Region (2025-2030)
5.3 Anticoagulants Market Dynamics
5.3.1 Anticoagulants Industry Trends
5.3.2 Anticoagulants Market Drivers
5.3.3 Anticoagulants Market Challenges
5.3.4 Anticoagulants Market Restraints
6 MARKET COMPETITIVE LANDSCAPE BY PLAYERS
6.1 Global Top Anticoagulants Players by Revenue
6.1.1 Global Top Anticoagulants Players by Revenue (2019-2024)
6.1.2 Global Anticoagulants Revenue Market Share by Players (2019-2024)
6.2 Global Anticoagulants Industry Players Ranking, 2022 VS 2023 VS 2024
6.3 Global Key Players of Anticoagulants Head office and Area Served
6.4 Global Anticoagulants Players, Product Type & Application
6.5 Global Anticoagulants Players, Date of Enter into This Industry
6.6 Global Anticoagulants Market CR5 and HHI
6.7 Global Players Mergers & Acquisition
7 NORTH AMERICA
7.1 North America Anticoagulants Market Size (2019-2030)
7.2 North America Anticoagulants Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 North America Anticoagulants Market Size by Country (2019-2024)
7.4 North America Anticoagulants Market Size by Country (2025-2030)
7.5 United States
7.6 Canada
8 EUROPE
8.1 Europe Anticoagulants Market Size (2019-2030)
8.2 Europe Anticoagulants Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Europe Anticoagulants Market Size by Country (2019-2024)
8.4 Europe Anticoagulants Market Size by Country (2025-2030)
8.5 Germany
8.6 France
8.7 U.K.
8.8 Italy
8.9 Russia
8.10 Nordic Countries
9 ASIA-PACIFIC
9.1 Asia-Pacific Anticoagulants Market Size (2019-2030)
9.2 Asia-Pacific Anticoagulants Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Asia-Pacific Anticoagulants Market Size by Country (2019-2024)
9.4 Asia-Pacific Anticoagulants Market Size by Country (2025-2030)
9.5 China
9.6 Japan
9.7 South Korea
9.8 Southeast Asia
9.9 India
9.10 Australia
10 LATIN AMERICA
10.1 Latin America Anticoagulants Market Size (2019-2030)
10.2 Latin America Anticoagulants Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Latin America Anticoagulants Market Size by Country (2019-2024)
10.4 Latin America Anticoagulants Market Size by Country (2025-2030)
10.5 Mexico
10.6 Brazil
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Anticoagulants Market Size (2019-2030)
11.2 Middle East & Africa Anticoagulants Market Growth Rate by Country: 2019 VS 2023 VS 2030
11.3 Middle East & Africa Anticoagulants Market Size by Country (2019-2024)
11.4 Middle East & Africa Anticoagulants Market Size by Country (2025-2030)
11.5 Turkey
11.6 Saudi Arabia
11.7 UAE
12 PLAYERS PROFILED
12.1 Sanofi
12.1.1 Sanofi Company Information
12.1.2 Sanofi Business Overview
12.1.3 Sanofi Revenue in Anticoagulants Business (2019-2024)
12.1.4 Sanofi Anticoagulants Product Portfolio
12.1.5 Sanofi Recent Developments
12.2 Bristol-Myers Squibb
12.2.1 Bristol-Myers Squibb Company Information
12.2.2 Bristol-Myers Squibb Business Overview
12.2.3 Bristol-Myers Squibb Revenue in Anticoagulants Business (2019-2024)
12.2.4 Bristol-Myers Squibb Anticoagulants Product Portfolio
12.2.5 Bristol-Myers Squibb Recent Developments
12.3 Bayer
12.3.1 Bayer Company Information
12.3.2 Bayer Business Overview
12.3.3 Bayer Revenue in Anticoagulants Business (2019-2024)
12.3.4 Bayer Anticoagulants Product Portfolio
12.3.5 Bayer Recent Developments
12.4 Johnson & Johnson.
12.4.1 Johnson & Johnson. Company Information
12.4.2 Johnson & Johnson. Business Overview
12.4.3 Johnson & Johnson. Revenue in Anticoagulants Business (2019-2024)
12.4.4 Johnson & Johnson. Anticoagulants Product Portfolio
12.4.5 Johnson & Johnson. Recent Developments
12.5 Genentech (Roche)
12.5.1 Genentech (Roche) Company Information
12.5.2 Genentech (Roche) Business Overview
12.5.3 Genentech (Roche) Revenue in Anticoagulants Business (2019-2024)
12.5.4 Genentech (Roche) Anticoagulants Product Portfolio
12.5.5 Genentech (Roche) Recent Developments
12.6 Boehringer Ingelheim
12.6.1 Boehringer Ingelheim Company Information
12.6.2 Boehringer Ingelheim Business Overview
12.6.3 Boehringer Ingelheim Revenue in Anticoagulants Business (2019-2024)
12.6.4 Boehringer Ingelheim Anticoagulants Product Portfolio
12.6.5 Boehringer Ingelheim Recent Developments
12.7 Lilly
12.7.1 Lilly Company Information
12.7.2 Lilly Business Overview
12.7.3 Lilly Revenue in Anticoagulants Business (2019-2024)
12.7.4 Lilly Anticoagulants Product Portfolio
12.7.5 Lilly Recent Developments
12.8 Daiichi Sankyo
12.8.1 Daiichi Sankyo Company Information
12.8.2 Daiichi Sankyo Business Overview
12.8.3 Daiichi Sankyo Revenue in Anticoagulants Business (2019-2024)
12.8.4 Daiichi Sankyo Anticoagulants Product Portfolio
12.8.5 Daiichi Sankyo Recent Developments
12.9 Otsuka
12.9.1 Otsuka Company Information
12.9.2 Otsuka Business Overview
12.9.3 Otsuka Revenue in Anticoagulants Business (2019-2024)
12.9.4 Otsuka Anticoagulants Product Portfolio
12.9.5 Otsuka Recent Developments
12.10 AstraZeneca
12.10.1 AstraZeneca Company Information
12.10.2 AstraZeneca Business Overview
12.10.3 AstraZeneca Revenue in Anticoagulants Business (2019-2024)
12.10.4 AstraZeneca Anticoagulants Product Portfolio
12.10.5 AstraZeneca Recent Developments
12.11 Pfizer
12.11.1 Pfizer Company Information
12.11.2 Pfizer Business Overview
12.11.3 Pfizer Revenue in Anticoagulants Business (2019-2024)
12.11.4 Pfizer Anticoagulants Product Portfolio
12.11.5 Pfizer Recent Developments
12.12 Aspen
12.12.1 Aspen Company Information
12.12.2 Aspen Business Overview
12.12.3 Aspen Revenue in Anticoagulants Business (2019-2024)
12.12.4 Aspen Anticoagulants Product Portfolio
12.12.5 Aspen Recent Developments
12.13 The Medicines Company
12.13.1 The Medicines Company Company Information
12.13.2 The Medicines Company Business Overview
12.13.3 The Medicines Company Revenue in Anticoagulants Business (2019-2024)
12.13.4 The Medicines Company Anticoagulants Product Portfolio
12.13.5 The Medicines Company Recent Developments
13 REPORT CONCLUSION
14 DISCLAIMER
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 MARKET OVERVIEW
2.1 Product Definition
2.2 Anticoagulants by Type
2.2.1 Market Value Comparison by Type (2019 VS 2023 VS 2030)
2.2.2 Platelet Aggregation Inhibitors (PAI)
2.2.3 Low-Molecular-Weight Heparin (LMWH)
2.2.4 Direct Thrombin Inhibitor (DTI)
2.2.5 Direct Factor Xa Inhibitors (DFXa)
2.2.6 Vitamin K antagonists (VKA)
2.2.7 Others
2.3 Anticoagulants by Application
2.3.1 Market Value Comparison by Application (2019 VS 2023 VS 2030)
2.3.2 VTE
2.3.3 ACS/MI
2.3.4 AF
2.3.5 Others
2.4 Assumptions and Limitations
3 ANTICOAGULANTS BREAKDOWN DATA BY TYPE
3.1 Global Anticoagulants Historic Market Size by Type (2019-2024)
3.2 Global Anticoagulants Forecasted Market Size by Type (2025-2030)
4 ANTICOAGULANTS BREAKDOWN DATA BY APPLICATION
4.1 Global Anticoagulants Historic Market Size by Application (2019-2024)
4.2 Global Anticoagulants Forecasted Market Size by Application (2019-2024)
5 GLOBAL GROWTH TRENDS
5.1 Global Anticoagulants Market Perspective (2019-2030)
5.2 Global Anticoagulants Growth Trends by Region
5.2.1 Global Anticoagulants Market Size by Region: 2019 VS 2023 VS 2030
5.2.2 Anticoagulants Historic Market Size by Region (2019-2024)
5.2.3 Anticoagulants Forecasted Market Size by Region (2025-2030)
5.3 Anticoagulants Market Dynamics
5.3.1 Anticoagulants Industry Trends
5.3.2 Anticoagulants Market Drivers
5.3.3 Anticoagulants Market Challenges
5.3.4 Anticoagulants Market Restraints
6 MARKET COMPETITIVE LANDSCAPE BY PLAYERS
6.1 Global Top Anticoagulants Players by Revenue
6.1.1 Global Top Anticoagulants Players by Revenue (2019-2024)
6.1.2 Global Anticoagulants Revenue Market Share by Players (2019-2024)
6.2 Global Anticoagulants Industry Players Ranking, 2022 VS 2023 VS 2024
6.3 Global Key Players of Anticoagulants Head office and Area Served
6.4 Global Anticoagulants Players, Product Type & Application
6.5 Global Anticoagulants Players, Date of Enter into This Industry
6.6 Global Anticoagulants Market CR5 and HHI
6.7 Global Players Mergers & Acquisition
7 NORTH AMERICA
7.1 North America Anticoagulants Market Size (2019-2030)
7.2 North America Anticoagulants Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 North America Anticoagulants Market Size by Country (2019-2024)
7.4 North America Anticoagulants Market Size by Country (2025-2030)
7.5 United States
7.6 Canada
8 EUROPE
8.1 Europe Anticoagulants Market Size (2019-2030)
8.2 Europe Anticoagulants Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Europe Anticoagulants Market Size by Country (2019-2024)
8.4 Europe Anticoagulants Market Size by Country (2025-2030)
8.5 Germany
8.6 France
8.7 U.K.
8.8 Italy
8.9 Russia
8.10 Nordic Countries
9 ASIA-PACIFIC
9.1 Asia-Pacific Anticoagulants Market Size (2019-2030)
9.2 Asia-Pacific Anticoagulants Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Asia-Pacific Anticoagulants Market Size by Country (2019-2024)
9.4 Asia-Pacific Anticoagulants Market Size by Country (2025-2030)
9.5 China
9.6 Japan
9.7 South Korea
9.8 Southeast Asia
9.9 India
9.10 Australia
10 LATIN AMERICA
10.1 Latin America Anticoagulants Market Size (2019-2030)
10.2 Latin America Anticoagulants Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Latin America Anticoagulants Market Size by Country (2019-2024)
10.4 Latin America Anticoagulants Market Size by Country (2025-2030)
10.5 Mexico
10.6 Brazil
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Anticoagulants Market Size (2019-2030)
11.2 Middle East & Africa Anticoagulants Market Growth Rate by Country: 2019 VS 2023 VS 2030
11.3 Middle East & Africa Anticoagulants Market Size by Country (2019-2024)
11.4 Middle East & Africa Anticoagulants Market Size by Country (2025-2030)
11.5 Turkey
11.6 Saudi Arabia
11.7 UAE
12 PLAYERS PROFILED
12.1 Sanofi
12.1.1 Sanofi Company Information
12.1.2 Sanofi Business Overview
12.1.3 Sanofi Revenue in Anticoagulants Business (2019-2024)
12.1.4 Sanofi Anticoagulants Product Portfolio
12.1.5 Sanofi Recent Developments
12.2 Bristol-Myers Squibb
12.2.1 Bristol-Myers Squibb Company Information
12.2.2 Bristol-Myers Squibb Business Overview
12.2.3 Bristol-Myers Squibb Revenue in Anticoagulants Business (2019-2024)
12.2.4 Bristol-Myers Squibb Anticoagulants Product Portfolio
12.2.5 Bristol-Myers Squibb Recent Developments
12.3 Bayer
12.3.1 Bayer Company Information
12.3.2 Bayer Business Overview
12.3.3 Bayer Revenue in Anticoagulants Business (2019-2024)
12.3.4 Bayer Anticoagulants Product Portfolio
12.3.5 Bayer Recent Developments
12.4 Johnson & Johnson.
12.4.1 Johnson & Johnson. Company Information
12.4.2 Johnson & Johnson. Business Overview
12.4.3 Johnson & Johnson. Revenue in Anticoagulants Business (2019-2024)
12.4.4 Johnson & Johnson. Anticoagulants Product Portfolio
12.4.5 Johnson & Johnson. Recent Developments
12.5 Genentech (Roche)
12.5.1 Genentech (Roche) Company Information
12.5.2 Genentech (Roche) Business Overview
12.5.3 Genentech (Roche) Revenue in Anticoagulants Business (2019-2024)
12.5.4 Genentech (Roche) Anticoagulants Product Portfolio
12.5.5 Genentech (Roche) Recent Developments
12.6 Boehringer Ingelheim
12.6.1 Boehringer Ingelheim Company Information
12.6.2 Boehringer Ingelheim Business Overview
12.6.3 Boehringer Ingelheim Revenue in Anticoagulants Business (2019-2024)
12.6.4 Boehringer Ingelheim Anticoagulants Product Portfolio
12.6.5 Boehringer Ingelheim Recent Developments
12.7 Lilly
12.7.1 Lilly Company Information
12.7.2 Lilly Business Overview
12.7.3 Lilly Revenue in Anticoagulants Business (2019-2024)
12.7.4 Lilly Anticoagulants Product Portfolio
12.7.5 Lilly Recent Developments
12.8 Daiichi Sankyo
12.8.1 Daiichi Sankyo Company Information
12.8.2 Daiichi Sankyo Business Overview
12.8.3 Daiichi Sankyo Revenue in Anticoagulants Business (2019-2024)
12.8.4 Daiichi Sankyo Anticoagulants Product Portfolio
12.8.5 Daiichi Sankyo Recent Developments
12.9 Otsuka
12.9.1 Otsuka Company Information
12.9.2 Otsuka Business Overview
12.9.3 Otsuka Revenue in Anticoagulants Business (2019-2024)
12.9.4 Otsuka Anticoagulants Product Portfolio
12.9.5 Otsuka Recent Developments
12.10 AstraZeneca
12.10.1 AstraZeneca Company Information
12.10.2 AstraZeneca Business Overview
12.10.3 AstraZeneca Revenue in Anticoagulants Business (2019-2024)
12.10.4 AstraZeneca Anticoagulants Product Portfolio
12.10.5 AstraZeneca Recent Developments
12.11 Pfizer
12.11.1 Pfizer Company Information
12.11.2 Pfizer Business Overview
12.11.3 Pfizer Revenue in Anticoagulants Business (2019-2024)
12.11.4 Pfizer Anticoagulants Product Portfolio
12.11.5 Pfizer Recent Developments
12.12 Aspen
12.12.1 Aspen Company Information
12.12.2 Aspen Business Overview
12.12.3 Aspen Revenue in Anticoagulants Business (2019-2024)
12.12.4 Aspen Anticoagulants Product Portfolio
12.12.5 Aspen Recent Developments
12.13 The Medicines Company
12.13.1 The Medicines Company Company Information
12.13.2 The Medicines Company Business Overview
12.13.3 The Medicines Company Revenue in Anticoagulants Business (2019-2024)
12.13.4 The Medicines Company Anticoagulants Product Portfolio
12.13.5 The Medicines Company Recent Developments
13 REPORT CONCLUSION
14 DISCLAIMER
LIST OF TABLES
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
Table 4. Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
Table 5. Global Anticoagulants Market Size by Type (2018-2023) & (US$ Million)
Table 6. Global Anticoagulants Revenue Market Share by Type (2018-2023)
Table 7. Global Anticoagulants Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 8. Global Anticoagulants Revenue Market Share by Type (2024-2029)
Table 9. Global Anticoagulants Market Size by Application (2018-2023) & (US$ Million)
Table 10. Global Anticoagulants Revenue Market Share by Application (2018-2023)
Table 11. Global Anticoagulants Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 12. Global Anticoagulants Revenue Market Share by Application (2024-2029)
Table 13. Global Anticoagulants Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 14. Global Anticoagulants Market Size by Region (2018-2023) & (US$ Million)
Table 15. Global Anticoagulants Market Share by Region (2018-2023)
Table 16. Global Anticoagulants Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 17. Global Anticoagulants Market Share by Region (2024-2029)
Table 18. Anticoagulants Market Trends
Table 19. Anticoagulants Market Drivers
Table 20. Anticoagulants Market Challenges
Table 21. Anticoagulants Market Restraints
Table 22. Global Top Anticoagulants Manufacturers by Revenue (US$ Million) & (2018-2023)
Table 23. Global Anticoagulants Revenue Market Share by Manufacturers (2018-2023)
Table 24. Global Anticoagulants Industry Manufacturers Ranking, 2021 VS 2022 VS 2023
Table 25. Global Key Players of Anticoagulants, Headquarters and Area Served
Table 26. Global Anticoagulants Manufacturers, Product Type & Application
Table 27. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 28. Global Anticoagulants by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2022)
Table 29. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 30. North America Anticoagulants Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. North America Anticoagulants Market Size by Country (2018-2023) & (US$ Million)
Table 32. North America Anticoagulants Market Size by Country (2024-2029) & (US$ Million)
Table 33. Europe Anticoagulants Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 34. Europe Anticoagulants Market Size by Country (2018-2023) & (US$ Million)
Table 35. Europe Anticoagulants Market Size by Country (2024-2029) & (US$ Million)
Table 36. Asia-Pacific Anticoagulants Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 37. Asia-Pacific Anticoagulants Market Size by Country (2018-2023) & (US$ Million)
Table 38. Asia-Pacific Anticoagulants Market Size by Country (2024-2029) & (US$ Million)
Table 39. Latin America Anticoagulants Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 40. Latin America Anticoagulants Market Size by Country (2018-2023) & (US$ Million)
Table 41. Latin America Anticoagulants Market Size by Country (2024-2029) & (US$ Million)
Table 42. Middle East & Africa Anticoagulants Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 43. Middle East & Africa Anticoagulants Market Size by Country (2018-2023) & (US$ Million)
Table 44. Middle East & Africa Anticoagulants Market Size by Country (2024-2029) & (US$ Million)
Table 45. Sanofi Company Detail
Table 46. Sanofi Business Overview
Table 47. Sanofi Anticoagulants Product
Table 48. Sanofi Revenue in Anticoagulants Business (2017-2022) & (US$ Million)
Table 49. Sanofi Recent Development
Table 50. Bristol-Myers Squibb Company Detail
Table 51. Bristol-Myers Squibb Business Overview
Table 52. Bristol-Myers Squibb Anticoagulants Product
Table 53. Bristol-Myers Squibb Revenue in Anticoagulants Business (2017-2022) & (US$ Million)
Table 54. Bristol-Myers Squibb Recent Development
Table 55. Bayer Company Detail
Table 56. Bayer Business Overview
Table 57. Bayer Anticoagulants Product
Table 58. Bayer Revenue in Anticoagulants Business (2017-2022) & (US$ Million)
Table 59. Bayer Recent Development
Table 60. Johnson & Johnson. Company Detail
Table 61. Johnson & Johnson. Business Overview
Table 62. Johnson & Johnson. Anticoagulants Product
Table 63. Johnson & Johnson. Revenue in Anticoagulants Business (2017-2022) & (US$ Million)
Table 64. Johnson & Johnson. Recent Development
Table 65. Genentech (Roche) Company Detail
Table 66. Genentech (Roche) Business Overview
Table 67. Genentech (Roche) Anticoagulants Product
Table 68. Genentech (Roche) Revenue in Anticoagulants Business (2017-2022) & (US$ Million)
Table 69. Genentech (Roche) Recent Development
Table 70. Boehringer Ingelheim Company Detail
Table 71. Boehringer Ingelheim Business Overview
Table 72. Boehringer Ingelheim Anticoagulants Product
Table 73. Boehringer Ingelheim Revenue in Anticoagulants Business (2017-2022) & (US$ Million)
Table 74. Boehringer Ingelheim Recent Development
Table 75. Lilly Company Detail
Table 76. Lilly Business Overview
Table 77. Lilly Anticoagulants Product
Table 78. Lilly Revenue in Anticoagulants Business (2017-2022) & (US$ Million)
Table 79. Lilly Recent Development
Table 80. Daiichi Sankyo Company Detail
Table 81. Daiichi Sankyo Business Overview
Table 82. Daiichi Sankyo Anticoagulants Product
Table 83. Daiichi Sankyo Revenue in Anticoagulants Business (2017-2022) & (US$ Million)
Table 84. Daiichi Sankyo Recent Development
Table 85. Otsuka Company Detail
Table 86. Otsuka Business Overview
Table 87. Otsuka Anticoagulants Product
Table 88. Otsuka Revenue in Anticoagulants Business (2017-2022) & (US$ Million)
Table 89. Otsuka Recent Development
Table 90. AstraZeneca Company Detail
Table 91. AstraZeneca Business Overview
Table 92. AstraZeneca Anticoagulants Product
Table 93. AstraZeneca Revenue in Anticoagulants Business (2017-2022) & (US$ Million)
Table 94. AstraZeneca Recent Development
Table 95. Pfizer Company Detail
Table 96. Pfizer Business Overview
Table 97. Pfizer AnticoagulantsProduct
Table 98. Pfizer Revenue in Anticoagulants Business (2017-2022) & (US$ Million)
Table 99. Pfizer Recent Development
Table 100. Aspen Company Detail
Table 101. Aspen Business Overview
Table 102. Aspen AnticoagulantsProduct
Table 103. Aspen Revenue in Anticoagulants Business (2017-2022) & (US$ Million)
Table 104. Aspen Recent Development
Table 105. The Medicines Company Company Detail
Table 106. The Medicines Company Business Overview
Table 107. The Medicines Company AnticoagulantsProduct
Table 108. The Medicines Company Revenue in Anticoagulants Business (2017-2022) & (US$ Million)
Table 109. The Medicines Company Recent Development
Table 110. Sanofi Company Information
Table 111. Sanofi Business Overview
Table 112. Sanofi Anticoagulants Revenue in Anticoagulants Business (2018-2023) & (US$ Million)
Table 113. Sanofi Revenue in Anticoagulants Business (2018-2023) & (US$ Million) Portfolio
Table 114. Sanofi Recent Development
Table 115. Bristol-Myers Squibb Company Information
Table 116. Bristol-Myers Squibb Business Overview
Table 117. Bristol-Myers Squibb Anticoagulants Revenue in Anticoagulants Business (2018-2023) & (US$ Million)
Table 118. Bristol-Myers Squibb Revenue in Anticoagulants Business (2018-2023) & (US$ Million) Portfolio
Table 119. Bristol-Myers Squibb Recent Development
Table 120. Bayer Company Information
Table 121. Bayer Business Overview
Table 122. Bayer Anticoagulants Revenue in Anticoagulants Business (2018-2023) & (US$ Million)
Table 123. Bayer Revenue in Anticoagulants Business (2018-2023) & (US$ Million) Portfolio
Table 124. Bayer Recent Development
Table 125. Johnson & Johnson. Company Information
Table 126. Johnson & Johnson. Business Overview
Table 127. Johnson & Johnson. Anticoagulants Revenue in Anticoagulants Business (2018-2023) & (US$ Million)
Table 128. Johnson & Johnson. Revenue in Anticoagulants Business (2018-2023) & (US$ Million) Portfolio
Table 129. Johnson & Johnson. Recent Development
Table 130. Genentech (Roche) Company Information
Table 131. Genentech (Roche) Business Overview
Table 132. Genentech (Roche) Anticoagulants Revenue in Anticoagulants Business (2018-2023) & (US$ Million)
Table 133. Genentech (Roche) Revenue in Anticoagulants Business (2018-2023) & (US$ Million) Portfolio
Table 134. Genentech (Roche) Recent Development
Table 135. Boehringer Ingelheim Company Information
Table 136. Boehringer Ingelheim Business Overview
Table 137. Boehringer Ingelheim Anticoagulants Revenue in Anticoagulants Business (2018-2023) & (US$ Million)
Table 138. Boehringer Ingelheim Revenue in Anticoagulants Business (2018-2023) & (US$ Million) Portfolio
Table 139. Boehringer Ingelheim Recent Development
Table 140. Lilly Company Information
Table 141. Lilly Business Overview
Table 142. Lilly Anticoagulants Revenue in Anticoagulants Business (2018-2023) & (US$ Million)
Table 143. Lilly Revenue in Anticoagulants Business (2018-2023) & (US$ Million) Portfolio
Table 144. Lilly Recent Development
Table 145. Daiichi Sankyo Company Information
Table 146. Daiichi Sankyo Business Overview
Table 147. Daiichi Sankyo Anticoagulants Revenue in Anticoagulants Business (2018-2023) & (US$ Million)
Table 148. Daiichi Sankyo Revenue in Anticoagulants Business (2018-2023) & (US$ Million) Portfolio
Table 149. Daiichi Sankyo Recent Development
Table 150. Otsuka Company Information
Table 151. Otsuka Business Overview
Table 152. Otsuka Anticoagulants Revenue in Anticoagulants Business (2018-2023) & (US$ Million)
Table 153. Otsuka Revenue in Anticoagulants Business (2018-2023) & (US$ Million) Portfolio
Table 154. Otsuka Recent Development
Table 155. AstraZeneca Company Information
Table 156. AstraZeneca Business Overview
Table 157. AstraZeneca Anticoagulants Revenue in Anticoagulants Business (2018-2023) & (US$ Million)
Table 158. AstraZeneca Revenue in Anticoagulants Business (2018-2023) & (US$ Million) Portfolio
Table 159. AstraZeneca Recent Development
Table 160. Pfizer Company Information
Table 161. Pfizer Business Overview
Table 162. Pfizer AnticoagulantsRevenue in Anticoagulants Business (2018-2023) & (US$ Million)
Table 163. Pfizer Revenue in Anticoagulants Business (2018-2023) & (US$ Million) Portfolio
Table 164. Pfizer Recent Development
Table 165. Aspen Company Information
Table 166. Aspen Business Overview
Table 167. Aspen AnticoagulantsRevenue in Anticoagulants Business (2018-2023) & (US$ Million)
Table 168. Aspen Revenue in Anticoagulants Business (2018-2023) & (US$ Million) Portfolio
Table 169. Aspen Recent Development
Table 170. The Medicines Company Company Information
Table 171. The Medicines Company Business Overview
Table 172. The Medicines Company AnticoagulantsRevenue in Anticoagulants Business (2018-2023) & (US$ Million)
Table 173. The Medicines Company Revenue in Anticoagulants Business (2018-2023) & (US$ Million) Portfolio
Table 174. The Medicines Company Recent Development
Table 175. Authors List of This Report
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
Table 4. Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
Table 5. Global Anticoagulants Market Size by Type (2018-2023) & (US$ Million)
Table 6. Global Anticoagulants Revenue Market Share by Type (2018-2023)
Table 7. Global Anticoagulants Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 8. Global Anticoagulants Revenue Market Share by Type (2024-2029)
Table 9. Global Anticoagulants Market Size by Application (2018-2023) & (US$ Million)
Table 10. Global Anticoagulants Revenue Market Share by Application (2018-2023)
Table 11. Global Anticoagulants Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 12. Global Anticoagulants Revenue Market Share by Application (2024-2029)
Table 13. Global Anticoagulants Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 14. Global Anticoagulants Market Size by Region (2018-2023) & (US$ Million)
Table 15. Global Anticoagulants Market Share by Region (2018-2023)
Table 16. Global Anticoagulants Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 17. Global Anticoagulants Market Share by Region (2024-2029)
Table 18. Anticoagulants Market Trends
Table 19. Anticoagulants Market Drivers
Table 20. Anticoagulants Market Challenges
Table 21. Anticoagulants Market Restraints
Table 22. Global Top Anticoagulants Manufacturers by Revenue (US$ Million) & (2018-2023)
Table 23. Global Anticoagulants Revenue Market Share by Manufacturers (2018-2023)
Table 24. Global Anticoagulants Industry Manufacturers Ranking, 2021 VS 2022 VS 2023
Table 25. Global Key Players of Anticoagulants, Headquarters and Area Served
Table 26. Global Anticoagulants Manufacturers, Product Type & Application
Table 27. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 28. Global Anticoagulants by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2022)
Table 29. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 30. North America Anticoagulants Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. North America Anticoagulants Market Size by Country (2018-2023) & (US$ Million)
Table 32. North America Anticoagulants Market Size by Country (2024-2029) & (US$ Million)
Table 33. Europe Anticoagulants Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 34. Europe Anticoagulants Market Size by Country (2018-2023) & (US$ Million)
Table 35. Europe Anticoagulants Market Size by Country (2024-2029) & (US$ Million)
Table 36. Asia-Pacific Anticoagulants Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 37. Asia-Pacific Anticoagulants Market Size by Country (2018-2023) & (US$ Million)
Table 38. Asia-Pacific Anticoagulants Market Size by Country (2024-2029) & (US$ Million)
Table 39. Latin America Anticoagulants Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 40. Latin America Anticoagulants Market Size by Country (2018-2023) & (US$ Million)
Table 41. Latin America Anticoagulants Market Size by Country (2024-2029) & (US$ Million)
Table 42. Middle East & Africa Anticoagulants Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 43. Middle East & Africa Anticoagulants Market Size by Country (2018-2023) & (US$ Million)
Table 44. Middle East & Africa Anticoagulants Market Size by Country (2024-2029) & (US$ Million)
Table 45. Sanofi Company Detail
Table 46. Sanofi Business Overview
Table 47. Sanofi Anticoagulants Product
Table 48. Sanofi Revenue in Anticoagulants Business (2017-2022) & (US$ Million)
Table 49. Sanofi Recent Development
Table 50. Bristol-Myers Squibb Company Detail
Table 51. Bristol-Myers Squibb Business Overview
Table 52. Bristol-Myers Squibb Anticoagulants Product
Table 53. Bristol-Myers Squibb Revenue in Anticoagulants Business (2017-2022) & (US$ Million)
Table 54. Bristol-Myers Squibb Recent Development
Table 55. Bayer Company Detail
Table 56. Bayer Business Overview
Table 57. Bayer Anticoagulants Product
Table 58. Bayer Revenue in Anticoagulants Business (2017-2022) & (US$ Million)
Table 59. Bayer Recent Development
Table 60. Johnson & Johnson. Company Detail
Table 61. Johnson & Johnson. Business Overview
Table 62. Johnson & Johnson. Anticoagulants Product
Table 63. Johnson & Johnson. Revenue in Anticoagulants Business (2017-2022) & (US$ Million)
Table 64. Johnson & Johnson. Recent Development
Table 65. Genentech (Roche) Company Detail
Table 66. Genentech (Roche) Business Overview
Table 67. Genentech (Roche) Anticoagulants Product
Table 68. Genentech (Roche) Revenue in Anticoagulants Business (2017-2022) & (US$ Million)
Table 69. Genentech (Roche) Recent Development
Table 70. Boehringer Ingelheim Company Detail
Table 71. Boehringer Ingelheim Business Overview
Table 72. Boehringer Ingelheim Anticoagulants Product
Table 73. Boehringer Ingelheim Revenue in Anticoagulants Business (2017-2022) & (US$ Million)
Table 74. Boehringer Ingelheim Recent Development
Table 75. Lilly Company Detail
Table 76. Lilly Business Overview
Table 77. Lilly Anticoagulants Product
Table 78. Lilly Revenue in Anticoagulants Business (2017-2022) & (US$ Million)
Table 79. Lilly Recent Development
Table 80. Daiichi Sankyo Company Detail
Table 81. Daiichi Sankyo Business Overview
Table 82. Daiichi Sankyo Anticoagulants Product
Table 83. Daiichi Sankyo Revenue in Anticoagulants Business (2017-2022) & (US$ Million)
Table 84. Daiichi Sankyo Recent Development
Table 85. Otsuka Company Detail
Table 86. Otsuka Business Overview
Table 87. Otsuka Anticoagulants Product
Table 88. Otsuka Revenue in Anticoagulants Business (2017-2022) & (US$ Million)
Table 89. Otsuka Recent Development
Table 90. AstraZeneca Company Detail
Table 91. AstraZeneca Business Overview
Table 92. AstraZeneca Anticoagulants Product
Table 93. AstraZeneca Revenue in Anticoagulants Business (2017-2022) & (US$ Million)
Table 94. AstraZeneca Recent Development
Table 95. Pfizer Company Detail
Table 96. Pfizer Business Overview
Table 97. Pfizer AnticoagulantsProduct
Table 98. Pfizer Revenue in Anticoagulants Business (2017-2022) & (US$ Million)
Table 99. Pfizer Recent Development
Table 100. Aspen Company Detail
Table 101. Aspen Business Overview
Table 102. Aspen AnticoagulantsProduct
Table 103. Aspen Revenue in Anticoagulants Business (2017-2022) & (US$ Million)
Table 104. Aspen Recent Development
Table 105. The Medicines Company Company Detail
Table 106. The Medicines Company Business Overview
Table 107. The Medicines Company AnticoagulantsProduct
Table 108. The Medicines Company Revenue in Anticoagulants Business (2017-2022) & (US$ Million)
Table 109. The Medicines Company Recent Development
Table 110. Sanofi Company Information
Table 111. Sanofi Business Overview
Table 112. Sanofi Anticoagulants Revenue in Anticoagulants Business (2018-2023) & (US$ Million)
Table 113. Sanofi Revenue in Anticoagulants Business (2018-2023) & (US$ Million) Portfolio
Table 114. Sanofi Recent Development
Table 115. Bristol-Myers Squibb Company Information
Table 116. Bristol-Myers Squibb Business Overview
Table 117. Bristol-Myers Squibb Anticoagulants Revenue in Anticoagulants Business (2018-2023) & (US$ Million)
Table 118. Bristol-Myers Squibb Revenue in Anticoagulants Business (2018-2023) & (US$ Million) Portfolio
Table 119. Bristol-Myers Squibb Recent Development
Table 120. Bayer Company Information
Table 121. Bayer Business Overview
Table 122. Bayer Anticoagulants Revenue in Anticoagulants Business (2018-2023) & (US$ Million)
Table 123. Bayer Revenue in Anticoagulants Business (2018-2023) & (US$ Million) Portfolio
Table 124. Bayer Recent Development
Table 125. Johnson & Johnson. Company Information
Table 126. Johnson & Johnson. Business Overview
Table 127. Johnson & Johnson. Anticoagulants Revenue in Anticoagulants Business (2018-2023) & (US$ Million)
Table 128. Johnson & Johnson. Revenue in Anticoagulants Business (2018-2023) & (US$ Million) Portfolio
Table 129. Johnson & Johnson. Recent Development
Table 130. Genentech (Roche) Company Information
Table 131. Genentech (Roche) Business Overview
Table 132. Genentech (Roche) Anticoagulants Revenue in Anticoagulants Business (2018-2023) & (US$ Million)
Table 133. Genentech (Roche) Revenue in Anticoagulants Business (2018-2023) & (US$ Million) Portfolio
Table 134. Genentech (Roche) Recent Development
Table 135. Boehringer Ingelheim Company Information
Table 136. Boehringer Ingelheim Business Overview
Table 137. Boehringer Ingelheim Anticoagulants Revenue in Anticoagulants Business (2018-2023) & (US$ Million)
Table 138. Boehringer Ingelheim Revenue in Anticoagulants Business (2018-2023) & (US$ Million) Portfolio
Table 139. Boehringer Ingelheim Recent Development
Table 140. Lilly Company Information
Table 141. Lilly Business Overview
Table 142. Lilly Anticoagulants Revenue in Anticoagulants Business (2018-2023) & (US$ Million)
Table 143. Lilly Revenue in Anticoagulants Business (2018-2023) & (US$ Million) Portfolio
Table 144. Lilly Recent Development
Table 145. Daiichi Sankyo Company Information
Table 146. Daiichi Sankyo Business Overview
Table 147. Daiichi Sankyo Anticoagulants Revenue in Anticoagulants Business (2018-2023) & (US$ Million)
Table 148. Daiichi Sankyo Revenue in Anticoagulants Business (2018-2023) & (US$ Million) Portfolio
Table 149. Daiichi Sankyo Recent Development
Table 150. Otsuka Company Information
Table 151. Otsuka Business Overview
Table 152. Otsuka Anticoagulants Revenue in Anticoagulants Business (2018-2023) & (US$ Million)
Table 153. Otsuka Revenue in Anticoagulants Business (2018-2023) & (US$ Million) Portfolio
Table 154. Otsuka Recent Development
Table 155. AstraZeneca Company Information
Table 156. AstraZeneca Business Overview
Table 157. AstraZeneca Anticoagulants Revenue in Anticoagulants Business (2018-2023) & (US$ Million)
Table 158. AstraZeneca Revenue in Anticoagulants Business (2018-2023) & (US$ Million) Portfolio
Table 159. AstraZeneca Recent Development
Table 160. Pfizer Company Information
Table 161. Pfizer Business Overview
Table 162. Pfizer AnticoagulantsRevenue in Anticoagulants Business (2018-2023) & (US$ Million)
Table 163. Pfizer Revenue in Anticoagulants Business (2018-2023) & (US$ Million) Portfolio
Table 164. Pfizer Recent Development
Table 165. Aspen Company Information
Table 166. Aspen Business Overview
Table 167. Aspen AnticoagulantsRevenue in Anticoagulants Business (2018-2023) & (US$ Million)
Table 168. Aspen Revenue in Anticoagulants Business (2018-2023) & (US$ Million) Portfolio
Table 169. Aspen Recent Development
Table 170. The Medicines Company Company Information
Table 171. The Medicines Company Business Overview
Table 172. The Medicines Company AnticoagulantsRevenue in Anticoagulants Business (2018-2023) & (US$ Million)
Table 173. The Medicines Company Revenue in Anticoagulants Business (2018-2023) & (US$ Million) Portfolio
Table 174. The Medicines Company Recent Development
Table 175. Authors List of This Report
LIST OF FIGURES
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Anticoagulants Product Picture
Figure 5. Global Anticoagulants Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 6. Global Anticoagulants Market Share by Type: 2022 VS 2029
Figure 7. Platelet Aggregation Inhibitors (PAI) Product Picture
Figure 8. Low-Molecular-Weight Heparin (LMWH) Product Picture
Figure 9. Direct Thrombin Inhibitor (DTI) Product Picture
Figure 10. Direct Factor Xa Inhibitors (DFXa) Product Picture
Figure 11. Vitamin K antagonists (VKA) Product Picture
Figure 12. Others Product Picture
Figure 13. Global Anticoagulants Market Size by Application (2023-2029) & (US$ Million)
Figure 14. Global Anticoagulants Market Share by Application: 2022 VS 2029
Figure 15. VTE Product Picture
Figure 16. ACS/MI Product Picture
Figure 17. AF Product Picture
Figure 18. Others Product Picture
Figure 19. Global Anticoagulants Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 20. Global Anticoagulants Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 21. Global Anticoagulants Market Share by Region: 2022 VS 2029
Figure 22. Global Anticoagulants Market Share by Players in 2022
Figure 23. Global Anticoagulants Players, Date of Enter into This Industry
Figure 24. Global Top 5 and 10 Anticoagulants Players Market Share by Revenue in 2022
Figure 25. Players Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 26. North America Anticoagulants Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. North America Anticoagulants Market Share by Country (2018-2029)
Figure 28. United States Anticoagulants Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Canada Anticoagulants Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Europe Anticoagulants Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Europe Anticoagulants Market Share by Country (2018-2029)
Figure 32. Germany Anticoagulants Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. France Anticoagulants Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. U.K. Anticoagulants Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Italy Anticoagulants Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Russia Anticoagulants Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Nordic Countries Anticoagulants Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Asia-Pacific Anticoagulants Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Asia-Pacific Anticoagulants Market Share by Country (2018-2029)
Figure 40. China Anticoagulants Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Japan Anticoagulants Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. South Korea Anticoagulants Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Southeast Asia Anticoagulants Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. India Anticoagulants Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Australia Anticoagulants Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Latin America Anticoagulants Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Latin America Anticoagulants Market Share by Country (2018-2029)
Figure 48. Mexico Anticoagulants Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 49. Brazil Anticoagulants Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 50. Middle East & Africa Anticoagulants Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 51. Middle East & Africa Anticoagulants Market Share by Country (2018-2029)
Figure 52. Turkey Anticoagulants Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Saudi Arabia Anticoagulants Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. UAE Anticoagulants Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. Sanofi Revenue Growth Rate in Anticoagulants Business (2018-2023)
Figure 56. Bristol-Myers Squibb Revenue Growth Rate in Anticoagulants Business (2018-2023)
Figure 57. Bayer Revenue Growth Rate in Anticoagulants Business (2018-2023)
Figure 58. Johnson & Johnson. Revenue Growth Rate in Anticoagulants Business (2018-2023)
Figure 59. Genentech (Roche) Revenue Growth Rate in Anticoagulants Business (2018-2023)
Figure 60. Boehringer Ingelheim Revenue Growth Rate in Anticoagulants Business (2018-2023)
Figure 61. Lilly Revenue Growth Rate in Anticoagulants Business (2018-2023)
Figure 62. Daiichi Sankyo Revenue Growth Rate in Anticoagulants Business (2018-2023)
Figure 63. Otsuka Revenue Growth Rate in Anticoagulants Business (2018-2023)
Figure 64. AstraZeneca Revenue Growth Rate in Anticoagulants Business (2018-2023)
Figure 65. Pfizer Revenue Growth Rate in Anticoagulants Business (2018-2023)
Figure 66. Aspen Revenue Growth Rate in Anticoagulants Business (2018-2023)
Figure 67. The Medicines Company Revenue Growth Rate in Anticoagulants Business (2018-2023)
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Anticoagulants Product Picture
Figure 5. Global Anticoagulants Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 6. Global Anticoagulants Market Share by Type: 2022 VS 2029
Figure 7. Platelet Aggregation Inhibitors (PAI) Product Picture
Figure 8. Low-Molecular-Weight Heparin (LMWH) Product Picture
Figure 9. Direct Thrombin Inhibitor (DTI) Product Picture
Figure 10. Direct Factor Xa Inhibitors (DFXa) Product Picture
Figure 11. Vitamin K antagonists (VKA) Product Picture
Figure 12. Others Product Picture
Figure 13. Global Anticoagulants Market Size by Application (2023-2029) & (US$ Million)
Figure 14. Global Anticoagulants Market Share by Application: 2022 VS 2029
Figure 15. VTE Product Picture
Figure 16. ACS/MI Product Picture
Figure 17. AF Product Picture
Figure 18. Others Product Picture
Figure 19. Global Anticoagulants Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 20. Global Anticoagulants Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 21. Global Anticoagulants Market Share by Region: 2022 VS 2029
Figure 22. Global Anticoagulants Market Share by Players in 2022
Figure 23. Global Anticoagulants Players, Date of Enter into This Industry
Figure 24. Global Top 5 and 10 Anticoagulants Players Market Share by Revenue in 2022
Figure 25. Players Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 26. North America Anticoagulants Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. North America Anticoagulants Market Share by Country (2018-2029)
Figure 28. United States Anticoagulants Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Canada Anticoagulants Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Europe Anticoagulants Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Europe Anticoagulants Market Share by Country (2018-2029)
Figure 32. Germany Anticoagulants Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. France Anticoagulants Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. U.K. Anticoagulants Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Italy Anticoagulants Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Russia Anticoagulants Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Nordic Countries Anticoagulants Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Asia-Pacific Anticoagulants Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Asia-Pacific Anticoagulants Market Share by Country (2018-2029)
Figure 40. China Anticoagulants Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Japan Anticoagulants Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. South Korea Anticoagulants Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Southeast Asia Anticoagulants Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. India Anticoagulants Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Australia Anticoagulants Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Latin America Anticoagulants Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Latin America Anticoagulants Market Share by Country (2018-2029)
Figure 48. Mexico Anticoagulants Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 49. Brazil Anticoagulants Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 50. Middle East & Africa Anticoagulants Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 51. Middle East & Africa Anticoagulants Market Share by Country (2018-2029)
Figure 52. Turkey Anticoagulants Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Saudi Arabia Anticoagulants Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. UAE Anticoagulants Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. Sanofi Revenue Growth Rate in Anticoagulants Business (2018-2023)
Figure 56. Bristol-Myers Squibb Revenue Growth Rate in Anticoagulants Business (2018-2023)
Figure 57. Bayer Revenue Growth Rate in Anticoagulants Business (2018-2023)
Figure 58. Johnson & Johnson. Revenue Growth Rate in Anticoagulants Business (2018-2023)
Figure 59. Genentech (Roche) Revenue Growth Rate in Anticoagulants Business (2018-2023)
Figure 60. Boehringer Ingelheim Revenue Growth Rate in Anticoagulants Business (2018-2023)
Figure 61. Lilly Revenue Growth Rate in Anticoagulants Business (2018-2023)
Figure 62. Daiichi Sankyo Revenue Growth Rate in Anticoagulants Business (2018-2023)
Figure 63. Otsuka Revenue Growth Rate in Anticoagulants Business (2018-2023)
Figure 64. AstraZeneca Revenue Growth Rate in Anticoagulants Business (2018-2023)
Figure 65. Pfizer Revenue Growth Rate in Anticoagulants Business (2018-2023)
Figure 66. Aspen Revenue Growth Rate in Anticoagulants Business (2018-2023)
Figure 67. The Medicines Company Revenue Growth Rate in Anticoagulants Business (2018-2023)
